Valuation : Camurus AB

Market Cap 35.32B 3.68B 3.16B 2.98B 2.72B 5.08B 350B 5.1B 13.65B 178B 13.81B 13.51B 565B P/E 2026 *
36.9x
P/E 2027 * 23.9x
Enterprise Value 30.8B 3.21B 2.76B 2.6B 2.37B 4.43B 305B 4.45B 11.9B 155B 12.04B 11.78B 493B EV / Sales 2026 *
10.8x
EV / Sales 2027 * 7.87x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-1.73%
1 week-0.93%
Current month+0.86%
1 month-3.37%
3 months+8.28%
6 months+23.12%
Current year-4.46%
1 week 573.5
Extreme 573.5
608.5
1 month 571.5
Extreme 571.5
644.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 282
Extreme 282
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
7/8/26 Sell

Executive/Senior Manager

-5,800 0.0096%
27/2/26 Sell

Chief Executive Officer

55,550 0.0928%
27/2/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-0.84%-0.93%-19.77%+98.68% 3.69B
+0.13%-2.84%+50.17%+89.26% 1,002B
-0.77%-2.71%+51.31%+64.61% 649B
+0.18%-4.70%+18.53%+67.34% 440B
-0.80%-0.43%+28.92%+36.94% 346B
-0.13%-14.97%+9.41%+26.44% 263B
-1.90%-2.72%-2.72%+10.93% 250B
-0.48%-11.58%+39.85%+49.61% 213B
-1.06%-4.23%-14.70%-57.76% 201B
-0.70%-2.65%+25.82%+89.05% 182B
Average -0.70%-1.80%+18.68%+47.51% 354.74B
Weighted average by Cap. -0.41%-2.38%+32.03%+56.07%

Financials

2026 *2027 *
Net sales 2.86B 297M 256M 241M 220M 411M 28.31B 413M 1.1B 14.42B 1.12B 1.09B 45.69B 3.75B 390M 336M 316M 288M 539M 37.14B 541M 1.45B 18.92B 1.47B 1.43B 59.94B
Net income 949M 98.83M 85.05M 80.08M 72.96M 137M 9.4B 137M 367M 4.79B 371M 363M 15.18B 1.45B 151M 130M 123M 112M 209M 14.39B 210M 561M 7.33B 568M 556M 23.23B
Net Debt -4.52B -470M -405M -381M -347M -650M -44.76B -652M -1.75B -22.8B -1.77B -1.73B -72.24B -5.81B -605M -520M -490M -446M -835M -57.54B -839M -2.24B -29.32B -2.27B -2.22B -92.87B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
10/09/26 SEK 588.50 -0.84% 70,273
08/09/26 SEK 593.50 +2.50% 75,518
07/09/26 SEK 579.00 -1.36% 45,422
04/09/26 SEK 587.00 -2.17% 40,835
03/09/26 SEK 600.00 +1.01% 51,590
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
593.50SEK
Average target price
793.00SEK
Spread / Average Target
+33.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!